However, induction of diabetes was most likely due to the direct toxic effects of Streptozotocin, since GP33-specific CD8+ T cells were not detected in peripheral blood after Streptozotocin treatment (Figure 4E). The gene discussed is CD8A; the disease is diabetes mellitus.